Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease Ongoing Positive Interim Analysis – DMC Recommended Study Size of 350 patients Topline Results.
On June 30, 2022, Chancellor Kathaleen St. J. McCormick of the Delaware Court of Chancery denied a motion to dismiss stockholder derivative claims for alleged breaches of fiduciary duty.
Item 1.01 Entry into a Material Definitive Agreement.
Registered Direct Offering of Shares
On May 6, 2022, Palisade Bio, Inc. entered into securities
purchase agreements with certain institutional. | May 6, 2022
The Very Good Food Company Inc. (OTCQB:VRYYF) Q4 2021 Earnings Conference Call April 14, 2022 4:30 PM ET Company Participants Ana Silva - President and Interim CFO Janet Meiklejohn - VP of.